ClinicalTrials.Veeva

Menu

Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity

T

Turku University Hospital (TYKS)

Status and phase

Completed
Phase 4

Conditions

Humoral Immune Responses
Gut Microbiota
Skin Microbiota
Severity of Atopic Dermatitis

Treatments

Dietary Supplement: Casein hydrolysate added with LGG
Dietary Supplement: Infants drink casein hydrolysate without LGG

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01148667
12/2006 1 531

Details and patient eligibility

About

Hypothesis: Probiotics have been used as novel adjunct therapeutic approach in atopic dermatitis. In addition to balancing the gut microecology and promoting host immune defences, specific probiotics might further aid in controlling the microbial colonization of the skin, thereby reducing proneness to secondary infections which typically cause sustained symptoms.

Thirty-nine infants with atopic dermatitis,randomized for a three-month-period in a double-blind design to receive extensively hydrolysed casein formula (NutramigenR, Mead-Johnson, USA) supplemented with (n=19) or without (n=20) Lactobacillus rhamnosus GG (ATCC 53103) 5.0 x 107 cfu/g to achieve a daily intake of 3.4 x 109 cfu.

Sampling (blood and faecal samples, cotton swab from the skin) and clinical examination of the infant, including SCORAD assessment to determine the severity of atopic dermatitis, at each study visit (at entry and one month and three months thereafter).

Enrollment

40 patients

Sex

All

Ages

4 weeks to 18 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of atopic dermatitis
  • age 4 we - 18 mo

Exclusion criteria

  • skin infection or severe infection at the time of enrollment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups, including a placebo group

Infants drink formula added with LGG
Active Comparator group
Description:
Infants have been randomized (1:1) to get casein hydrolysate with or without LGG
Treatment:
Dietary Supplement: Casein hydrolysate added with LGG
Infants drink casein hydrolysate without LGG
Placebo Comparator group
Description:
Infants get extensively hydrolysed casein formula
Treatment:
Dietary Supplement: Infants drink casein hydrolysate without LGG

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems